Kiniksa Pharmaceuticals International Plc (KNSA)
41.05
-1.62
(-3.80%)
USD |
NASDAQ |
Jan 12, 16:00
41.05
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Research and Development Expense (Quarterly): 24.14M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 2.346M |
| ADMA Biologics, Inc. | 1.528M |
| NovoCure Ltd. | 54.03M |
| LivaNova Plc | 48.58M |
| Akanda Corp. | -- |